MedPath

An experimental study comparing the effects of treatment response and severity of difficulty in swallowing in patients with pharynx or larynx cancer treated with two different radiation techniques (D0-IMRT versus standard IMRT).

Phase 2
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2021/08/036041
Lead Sponsor
Karthik Subramaniam Thiagarajan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients with stage T2-T4, N+, M0 carcinoma of oropharynx, hypopharynx or larynx with squamous cell carcinoma histology only

2) ECOG performance 0-2

3) Written informed consent.

Exclusion Criteria

• Patients with head and neck cancer with non-squamous cell carcinoma histology

• Cancer sites other than oropharynx, hypopharynx, or supraglottic larynx

• Patients with T1 N0 M0 (or M1) disease in the above-mentioned sites

• Patients with recurrent cancer in the above-mentioned sites

• Patients not fit for concurrent chemoradiation (or receiving chemotherapy other than weekly cisplatin)

• Documented evidence of pre-existing swallowing dysfunction (not related to cancer)

• Previous radiotherapy to the head and neck region

• ECOG performance 3-4

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath